Based on the notion that the genome can change the phenotype of an assumed strong canalized gene such as Trp53, we surveyed the literature and JAX repository data, and analyzed the genomic differences based on haplotypes between tumor prone strains and tumor resistant strains. This evidence concerns the gene TP53 and neoplasm.